Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Chlamydia mRNA Vaccine

Vaccine (mRNA vaccine) · Immune activation · developed by Sanofi

Phase 1 Most advanced trial
SNY Developer

What is Chlamydia mRNA Vaccine?

Chlamydia mRNA Vaccine is an mRNA vaccine given by intramuscular injection as a suspension. It is studied for immunization against Chlamydia trachomatis infection.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Vaccine (mRNA vaccine)
Mechanism
Immune activation
Therapy area
Infectious disease
Developer
Sanofi (SNY)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1

Conditions studied

Chlamydia Trachomatis Immunization

More from Sanofi

Sources

Updated Nov 8, 2026. Something wrong or missing? Report it on the SNY page.

Follow SNY, the company behind Chlamydia mRNA Vaccine

See SNY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

SNY catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.